Suven Pharmaceuticals Limited (SUVENPHAR) — Cash Flow Quality Index
Suven Pharmaceuticals Limited (SUVENPHAR) has a Cash Flow Quality Index of 0.55x as of December 2023. Operating cash flow of Rs255.04 Million is below net income of Rs467.54 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore SUVENPHAR total assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Suven Pharmaceuticals Limited Cash Flow Quality Index (2019–2025)
Historical Cash Flow Quality Index for Suven Pharmaceuticals Limited across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible equity quality of Suven Pharmaceuticals Limited to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Suven Pharmaceuticals Limited (2019–2025)
Year-by-year earnings quality comparison for Suven Pharmaceuticals Limited. For live market cap and the full company financial profile, see SUVENPHAR company net worth.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.84x | Rs2.88 Billion | Rs3.44 Billion | ▼ -29.8% |
| 2024 | 1.19x | Rs3.58 Billion | Rs3.00 Billion | ▲ +48.2% |
| 2023 | 0.81x | Rs4.51 Billion | Rs5.60 Billion | ▲ +63.0% |
| 2022 | 0.49x | Rs3.30 Billion | Rs6.68 Billion | ▼ -39.7% |
| 2021 | 0.82x | Rs3.83 Billion | Rs4.68 Billion | ▼ -20.3% |
| 2020 | 1.03x | Rs4.16 Billion | Rs4.05 Billion | ▲ +222.1% |
| 2019 | 0.32x | Rs504.05 Million | Rs1.58 Billion | — |